These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8858456)
1. Evaluation of high-level carbapenem resistance in atypical Serratia marcescens by a comparison with its revertants. Marumo K; Nagaki T; Nakamura Y J Antimicrob Chemother; 1996 Jul; 38(1):47-58. PubMed ID: 8858456 [TBL] [Abstract][Full Text] [Related]
2. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029 [TBL] [Abstract][Full Text] [Related]
3. Carbapenem-resistant Serratia marcescens isolates producing Bush group 2f beta-lactamase (SME-1) in the United States: results from the MYSTIC Programme. Gales AC; Biedenbach DJ; Winokur P; Hacek DM; Pfaller MA; Jones RN Diagn Microbiol Infect Dis; 2001 Feb; 39(2):125-7. PubMed ID: 11248526 [TBL] [Abstract][Full Text] [Related]
4. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases. Yang Y; Bhachech N; Bush K J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785 [TBL] [Abstract][Full Text] [Related]
11. SME-3, a novel member of the Serratia marcescens SME family of carbapenem-hydrolyzing beta-lactamases. Queenan AM; Shang W; Schreckenberger P; Lolans K; Bush K; Quinn J Antimicrob Agents Chemother; 2006 Oct; 50(10):3485-7. PubMed ID: 17005839 [TBL] [Abstract][Full Text] [Related]
12. [Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae]. Cai JC; Zhou HW; Chen GX; Zhang R Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):135-8. PubMed ID: 18353225 [TBL] [Abstract][Full Text] [Related]
13. In-vitro activity of biapenem, compared with imipenem and meropenem, against Pseudomonas aeruginosa strains and mutants with known resistance mechanisms. Chen HY; Livermore DM J Antimicrob Chemother; 1994 May; 33(5):949-58. PubMed ID: 8089068 [TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Osano E; Arakawa Y; Wacharotayankun R; Ohta M; Horii T; Ito H; Yoshimura F; Kato N Antimicrob Agents Chemother; 1994 Jan; 38(1):71-8. PubMed ID: 8141584 [TBL] [Abstract][Full Text] [Related]
15. Plasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens. Ito H; Arakawa Y; Ohsuka S; Wacharotayankun R; Kato N; Ohta M Antimicrob Agents Chemother; 1995 Apr; 39(4):824-9. PubMed ID: 7785978 [TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of a beta-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Yang YJ; Wu PJ; Livermore DM Antimicrob Agents Chemother; 1990 May; 34(5):755-8. PubMed ID: 2193618 [TBL] [Abstract][Full Text] [Related]
18. Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials. Iaconis JP; Pitkin DH; Sheikh W; Nadler HL Clin Infect Dis; 1997 Feb; 24 Suppl 2():S191-6. PubMed ID: 9126693 [TBL] [Abstract][Full Text] [Related]
19. Relative importances of outer membrane permeability and group 1 beta-lactamase as determinants of meropenem and imipenem activities against Enterobacter cloacae. Cornaglia G; Russell K; Satta G; Fontana R Antimicrob Agents Chemother; 1995 Feb; 39(2):350-5. PubMed ID: 7726496 [TBL] [Abstract][Full Text] [Related]